Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome

Author:

Braud Véronique M.1ORCID,Biton Jérôme234,Becht Etienne234,Knockaert Samantha234,Mansuet-Lupo Audrey2345,Cosson Estelle1,Damotte Diane2345,Alifano Marco46,Validire Pierre27,Anjuère Fabienne1,Cremer Isabelle234,Girard Nicolas89,Gossot Dominique10,Seguin-Givelet Agathe1011,Dieu-Nosjean Marie-Caroline234ORCID,Germain Claire234ORCID

Affiliation:

1. Université Côte d'Azur, CNRS UMR7275, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Valbonne, France

2. Laboratory “Immune Microenvironment and Tumors”, Department “Cancer, Immunology, Immunotherapy”, INSERM UMRS 1138, Cordeliers Research Center, Paris, France

3. University Pierre and Marie Curie/Paris VI, Paris, France

4. University Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France

5. Department of Pathology, Hôpitaux Universitaires Paris Centre, AP-HP, Paris, France

6. Department of Thoracic Surgery, Hôpitaux Universitaires Paris Centre, AP-HP, Paris, France

7. Department of Pathology, Institut Mutualiste Montsouris, Paris, France

8. University of Lyon, University Lyon 1, Lyon, France

9. Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France

10. Thoracic Department, Institut du Thorax Curie-Montsouris, Institut Mutualiste Montsouris, Paris, France

11. Paris 13 University, Sorbonne Paris Cité, Faculty of Medicine SMBH, Bobigny, France

Funder

Fondation ARC

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3